tiprankstipranks
Trending News
More News >
Caris Life Sciences, Inc. (CAI)
NASDAQ:CAI
US Market
Advertisement

Caris Life Sciences, Inc. (CAI) Stock Forecast & Price Target

Compare
83 Followers
See the Price Targets and Ratings of:

CAI Analyst Ratings

Strong Buy
9Ratings
Strong Buy
8 Buy
1 Hold
0 Sell
Based on 9 analysts giving stock ratings to
Caris
Life Sciences, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CAI Stock 12 Month Forecast

Average Price Target

$37.89
▼(-1.30% Downside)
Based on 9 Wall Street analysts offering 12 month price targets for Caris Life Sciences, Inc. in the last 3 months. The average price target is $37.89 with a high forecast of $45.00 and a low forecast of $32.00. The average price target represents a -1.30% change from the last price of $38.39.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"25":"$25","46":"$46","30.25":"$30.3","35.5":"$35.5","40.75":"$40.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":45,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$45.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":37.89,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$37.89</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$32.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[25,30.25,35.5,40.75,46],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.04,29.344615384615384,30.64923076923077,31.953846153846154,33.25846153846154,34.56307692307692,35.86769230769231,37.17230769230769,38.47692307692308,39.78153846153846,41.08615384615385,42.39076923076923,43.69538461538461,{"y":45,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.04,28.79769230769231,29.555384615384614,30.313076923076924,31.07076923076923,31.82846153846154,32.58615384615385,33.34384615384615,34.10153846153846,34.85923076923077,35.61692307692308,36.37461538461538,37.13230769230769,{"y":37.89,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.04,28.344615384615384,28.64923076923077,28.953846153846154,29.25846153846154,29.563076923076924,29.86769230769231,30.17230769230769,30.476923076923075,30.78153846153846,31.086153846153845,31.39076923076923,31.695384615384615,{"y":32,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27.25,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.25,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.25,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.25,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.25,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.25,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.25,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.25,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.25,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.25,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.51,"date":1751328000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.51,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.04,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$45.00Average Price Target$37.89Lowest Price Target$32.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on CAI
TR | OpenAI - 4o
TR | OpenAI - 4o
$35
Hold
-8.83%
Downside
Initiated
08/21/25
AI Generated ArticleAI Generated Article
TD Cowen
$32$38
Buy
-1.02%
Downside
Reiterated
08/13/25
Strong Performance and Growth Potential: Caris Life Sciences, Inc. Receives Buy Rating with Increased Price Target
Bank of America Securities Analyst forecast on CAI
Bank of America Securities
Bank of America Securities
$31$37
Buy
-3.62%
Downside
Reiterated
08/13/25
Bank of America Securities Sticks to Its Buy Rating for Caris Life Sciences, Inc. (CAI)
Citi
$34$42
Buy
9.40%
Upside
Reiterated
08/13/25
Citi Remains a Buy on Caris Life Sciences, Inc. (CAI)
J.P. Morgan Analyst forecast on CAI
J.P. Morgan
J.P. Morgan
$31$40
Buy
4.19%
Upside
Reiterated
08/13/25
J.P. Morgan Sticks to Their Buy Rating for Caris Life Sciences, Inc. (CAI)
Evercore ISI Analyst forecast on CAI
Evercore ISI
Evercore ISI
$33$40
Buy
4.19%
Upside
Reiterated
08/13/25
Evercore ISI Keeps Their Buy Rating on Caris Life Sciences, Inc. (CAI)The ‘Caris Whispers’ bode well for FY26 setup
BTIG
$38$45
Buy
17.22%
Upside
Reiterated
08/13/25
BTIG Sticks to Its Buy Rating for Caris Life Sciences, Inc. (CAI)Caris prints a huge beat as a public company – we reiterate our Buy rating and raise our PT from $38 to $45.
Wolfe Research Analyst forecast on CAI
Wolfe Research
Wolfe Research
$32
Buy
-16.64%
Downside
Initiated
07/14/25
Caris Life Sciences initiated with an Outperform at Wolfe ResearchCaris Life Sciences initiated with an Outperform at Wolfe Research
Guggenheim Analyst forecast on CAI
Guggenheim
Guggenheim
$32
Buy
-16.64%
Downside
Initiated
07/13/25
Caris Life Sciences initiated with a Buy at GuggenheimCaris Life Sciences initiated with a Buy at Guggenheim
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on CAI
TR | OpenAI - 4o
TR | OpenAI - 4o
$35
Hold
-8.83%
Downside
Initiated
08/21/25
AI Generated ArticleAI Generated Article
TD Cowen
$32$38
Buy
-1.02%
Downside
Reiterated
08/13/25
Strong Performance and Growth Potential: Caris Life Sciences, Inc. Receives Buy Rating with Increased Price Target
Bank of America Securities Analyst forecast on CAI
Bank of America Securities
Bank of America Securities
$31$37
Buy
-3.62%
Downside
Reiterated
08/13/25
Bank of America Securities Sticks to Its Buy Rating for Caris Life Sciences, Inc. (CAI)
Citi
$34$42
Buy
9.40%
Upside
Reiterated
08/13/25
Citi Remains a Buy on Caris Life Sciences, Inc. (CAI)
J.P. Morgan Analyst forecast on CAI
J.P. Morgan
J.P. Morgan
$31$40
Buy
4.19%
Upside
Reiterated
08/13/25
J.P. Morgan Sticks to Their Buy Rating for Caris Life Sciences, Inc. (CAI)
Evercore ISI Analyst forecast on CAI
Evercore ISI
Evercore ISI
$33$40
Buy
4.19%
Upside
Reiterated
08/13/25
Evercore ISI Keeps Their Buy Rating on Caris Life Sciences, Inc. (CAI)The ‘Caris Whispers’ bode well for FY26 setup
BTIG
$38$45
Buy
17.22%
Upside
Reiterated
08/13/25
BTIG Sticks to Its Buy Rating for Caris Life Sciences, Inc. (CAI)Caris prints a huge beat as a public company – we reiterate our Buy rating and raise our PT from $38 to $45.
Wolfe Research Analyst forecast on CAI
Wolfe Research
Wolfe Research
$32
Buy
-16.64%
Downside
Initiated
07/14/25
Caris Life Sciences initiated with an Outperform at Wolfe ResearchCaris Life Sciences initiated with an Outperform at Wolfe Research
Guggenheim Analyst forecast on CAI
Guggenheim
Guggenheim
$32
Buy
-16.64%
Downside
Initiated
07/13/25
Caris Life Sciences initiated with a Buy at GuggenheimCaris Life Sciences initiated with a Buy at Guggenheim
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Caris Life Sciences, Inc.

1 Month
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+24.00%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +24.00% per trade.
3 Months
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+31.40%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +31.40% per trade.
1 Year
Success Rate
2/2 ratings generated profit
100%
Average Return
+31.40%
reiterated a buy rating 16 days ago
Copying Mark Massaro's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +31.40% per trade.
2 Years
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+31.40%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +31.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CAI Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Strong Buy
0
0
Buy
6
12
Hold
0
1
Sell
0
0
Strong Sell
0
0
total
6
13
In the current month, CAI has received 12 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CAI average Analyst price target in the past 3 months is 37.89.
Each month's total comprises the sum of three months' worth of ratings.

CAI Financial Forecast

CAI Earnings Forecast

Next quarter’s earnings estimate for CAI is -$0.22 with a range of -$0.38 to -$0.16. The previous quarter’s EPS was -$7.97. CAI beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year CAI has Preformed in-line its overall industry.
Next quarter’s earnings estimate for CAI is -$0.22 with a range of -$0.38 to -$0.16. The previous quarter’s EPS was -$7.97. CAI beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year CAI has Preformed in-line its overall industry.

CAI Sales Forecast

Next quarter’s sales forecast for CAI is $138.04M with a range of $132.90M to $141.00M. The previous quarter’s sales results were $181.40M. CAI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 71.43% of the time in the same period. In the last calendar year CAI has Outperformed its overall industry.
Next quarter’s sales forecast for CAI is $138.04M with a range of $132.90M to $141.00M. The previous quarter’s sales results were $181.40M. CAI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 71.43% of the time in the same period. In the last calendar year CAI has Outperformed its overall industry.

CAI Stock Forecast FAQ

What is CAI’s average 12-month price target, according to analysts?
Based on analyst ratings, Caris Life Sciences, Inc.’s 12-month average price target is 37.89.
    What is CAI’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CAI, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is CAI a Buy, Sell or Hold?
        Caris Life Sciences, Inc. has a consensus rating of Strong Buy which is based on 8 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Caris Life Sciences, Inc.’s price target?
          The average price target for Caris Life Sciences, Inc. is 37.89. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $45.00 ,the lowest forecast is $32.00. The average price target represents -1.30% Decrease from the current price of $38.39.
            What do analysts say about Caris Life Sciences, Inc.?
            Caris Life Sciences, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
              How can I buy shares of CAI?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis